NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers.
Jeong J, Hausmann S, Dong H, Szczepski K, Flores NM, Garcia Gonzalez A, Shi L, Lu X, Lempiäinen J, Jakab M, Zeng L, Chasan T, Bareke E, Dong R, Carlson E, Padilla R, Husmann D, Thompson J, Shipman GA, Zahn E, Barnes CA, Khan LF, Albertorio-Sáez LM, Brill E, Kumary VUS, Marunde MR, Maryanski DN, Szany CC, Venters BJ, Windham CL, Nowakowski ME, Czaban I, Jaremko M, Keogh MC, Le K, Soth MJ, Garcia BA, Jaremko Ł, Majewski J, Mazur PK, Gozani O.
Jeong J, et al. Among authors: jaremko m.
Nature. 2026 Jan;649(8095):205-215. doi: 10.1038/s41586-025-09299-y. Epub 2025 Aug 6.
Nature. 2026.
PMID: 40770093